Finding 571374 (2023-004)

Material Weakness
Requirement
L
Questioned Costs
-
Year
2023
Accepted
2025-07-15

AI Summary

  • Core Issue: There is a material weakness in internal controls over the preparation and reconciliation of the Schedule of Expenditures of Federal Awards (SEFA), leading to inaccuracies in reporting federal awards.
  • Impacted Requirements: Compliance with 2 CFR §200.510(b) and §200.302 is at risk, as the SEFA does not accurately reflect federal expenditures and lacks proper documentation and reconciliation.
  • Recommended Follow-Up: Implement standardized reconciliation processes, enhance system controls for tracking expenditures, and provide training for staff to ensure accurate SEFA preparation and compliance.

Finding Text

Finding number: 2023-004 – Material Weakness in Internal Control Over Preparation, Reconciliation, and Retention of the Schedule of Expenditures of Federal Awards (SEFA) Federal Program #1 HIV Emergency Relief Project Grants: CFDA Number: 93.914 Federal Program #2 HIV Care Formula Grants): CFDA Number: 93.917 Federal Program #3: HIV Prevention Activities: CFDA Number: 93.941 Name of federal agency: U.S. Department of Health and Human Services (HHS) Name of pass-through entity: Multiple Repeat finding: No AIDS Arms, Inc. dba Prism Health North Texas and Subsidiary Schedule of Findings and Questioned Costs For the Year Ended December 31, 2023 SECTION III - SUMMARY OF FEDERAL AWARD FINDINGS AND QUESTIONED COSTS (continued) Criteria: Under 2 CFR §200.510(b), recipients of federal funds are required to prepare a Schedule of Expenditures of Federal Awards (SEFA) that fairly presents federal expenditures for each grant program and is derived from and supported by the entity's accounting records. Additionally, 2 CFR §200.302 requires that financial management systems adequately identify and account for federal awards to ensure accuracy and compliance with applicable federal requirements. Best practices dictate that federal expenditures should be reconciled regularly to the general ledger, and supporting documentation should be maintained to substantiate amounts reported on the SEFA. Condition: The Organization lacked adequate controls over the preparation, reconciliation, and retention of records related to the SEFA. Specifically:  The SEFA incorrectly reported certain federal awards as non-federal awards.  The SEFA is prepared based on amounts requested for reimbursement instead of directly based on expenditures incurred.  Reconciliation schedules that tied SEFA expenditures directly back to the expenses recorded in the general ledger could not be located.  Expenses recorded in the general ledger represent expenses incurred to operate the program in addition to direct grant expenditures; the Organization only requests reimbursement for direct program expenditures allowable under the program.  Documentation of Excel-based reconciliations did not agree to reported monthly expenditures, indicating manual reclassification entries between program codes that were not clearly supported. Cause: The deficiencies noted were primarily due to:  Lack of system controls to ensure that state and federal expenditures were separately tracked from non-grant funds spent within the same source codes.  Turnover in grants management personnel, which resulted in missing, incomplete, or inaccurate reconciling records. Possible effect: Without a complete and accurate SEFA, the Organization risks noncompliance with Uniform Guidance reporting requirements, which could impact its ability to receive and administer federal funds in the future. Additionally, inaccurate SEFA reporting increases the risk of errors in administering funds, questioned costs, and over or under expenditure of grants. Questioned cost: None identified at this time. AIDS Arms, Inc. dba Prism Health North Texas and Subsidiary Schedule of Findings and Questioned Costs For the Year Ended December 31, 2023 SECTION III - SUMMARY OF FEDERAL AWARD FINDINGS AND QUESTIONED COSTS (continued) Recommendation: We recommend that the Organization implement the following measures to improve SEFA preparation and record retention: 1. Develop a Standardized SEFA Reconciliation Process – Implement formal policies and procedures requiring that SEFA expenditures be reconciled to the general ledger on a monthly basis, with documentation maintained for audit purposes. 2. Enhance System Controls for Grant Expenditures – Modify the financial system to allow for the proper segregation of state and federal expenditures from non-grant funds, ensuring that expenditures are properly classified at the time of entry. 3. Require Monthly Documentation Reviews – Establish a control requiring management to review and approve SEFA reconciliation schedules on a monthly or quarterly basis to ensure accuracy and completeness. 4. Implement a Centralized Documentation Retention Policy – Require that all SEFA-related reconciliation records, including general ledger tie-outs and manual adjustments, be retained in a centralized, accessible location. 5. Provide Grants Management Training – Conduct training for grants management and accounting personnel on SEFA preparation requirements, including Uniform Guidance compliance and best practices for documentation and reconciliation. 6. By implementing these measures, the Organization can improve its internal controls over SEFA preparation, ensure compliance with Uniform Guidance, and reduce the risk of reporting inaccuracies. AIDS Arms, Inc. dba Prism Health North Texas and Subsidiary Schedule of Findings and Questioned Costs For the Year Ended December 31, 2023 SECTION III - SUMMARY OF FEDERAL AWARD FINDINGS AND QUESTIONED COSTS (continued) Views of responsible officials: Management partially agrees with the finding. While we acknowledge that documentation supporting SEFA reconciliation was incomplete, we believe that federal expenditures were properly accounted for. We would like to address some of the auditors' points individually: "The SEFA is prepared based on amounts requested for reimbursement instead of directly based on expenditures incurred." Most grant awards do not fully fund the programs they support, most grant awards do not run concurrently with Prism Health North Texas' fiscal year (i.e., with the Calendar Year), and most grant awards are not spent in equal monthly amounts. It is correct that the 2023 SEFA was based on grant-appropriate expenditures that occurred during Calendar Year 2023 and were submitted to those grant sponsors for reimbursement. This will not necessarily reach the full cost to Prism for each grant-supported program, nor is it likely to exactly match any annual grant award amount. "Expenses recorded in the general ledger represent expenses incurred to operate the program in addition to direct grant expenditures; the Organization only requests reimbursement for direct program expenditures allowable under the program." As we confirmed verbally with the audit partner on April 25, 2025, this statement is intended to provide information and context and is not a criticism or intended to point out any problem. As stated above, most grant awards do not fully fund the programs they support; therefore, the general ledger necessarily includes both expenses the sponsor will reimburse and expenses the sponsor will not reimburse. Nonetheless, we are enhancing our reconciliation procedures and documentation practices to fully meet audit requirements. Finding 2023-004 refers to the auditors' assessment of the SEFA preparation and reconciliation processes that occurred in Calendar Year 2023. As of this writing, Prism Health North Texas has already changed its SEFA preparation and reconciliation processes and meets many of the recommendations above. Action Taken: Documentation Retention – On April 25, 2025, management created a structured and easily accessible system for storing all relevant information for all grants management personnel. A logical naming system for files identifying the SEFA period, the funding agency and identified general ledger expenditures claimed on the SEFA. We are now documenting the difference between all GL transactions and those submitted for sponsor reimbursement (i.e., SEFA components) in a single document per fund code, arranged by fiscal year. Previously this documentation was kept by invoice and arranged by grant year. Management will continue to ensure all expenditure-related support, such as invoices and purchase orders, is saved electronically to all AIDS Arms, Inc. dba Prism Health North Texas and Subsidiary Schedule of Findings and Questioned Costs For the Year Ended December 31, 2023 SECTION III - SUMMARY OF FEDERAL AWARD FINDINGS AND QUESTIONED COSTS (continued) financial transactions. SEFA Reconciliation – Management has decided to move from an annual to quarterly SEFA reconciliation process to enhance the frequency of management oversight in SEFA draft preparation. VP of Finance will prepare the SEFA for independent review by the CFO. This will be put into a written policy/procedure. System Enhancements – Prism's current accounting system does not accommodate this. However, Prism is already in the later stages of selecting a new Enterprise Resource Planning (ERP) solution, with this as one of our key selection criteria. Our new ERP should allow for expenditures within the same cost center to be identified as grant-reimbursable or non-grant-reimbursable at the time of entry. We have identified opportunities in new financial management software solutions that we are scheduled to demo May 12th and the 16th of 2025. Opportunities such as: The ability to tag grant-reimbursable transactions, to segment our award cost center into two important categories. The full cost to manage a specific program. Identified cost claimed on the SEFA. Dedicated grant modules that will allow us to establish business rules and workflows to streamline and digitize critical aspects of grant management. Staff Engagement – Cross department coordination meetings occur monthly between the Finance organization and the Grants Management team to continue to foster alignment and collaboration in our grant cycles. A general overview of SEFA, including how to prepare and organize the monthly reconciliations, has already occurred with some of the grants accountants. _________________________________________________________

Categories

Reporting Internal Control / Segregation of Duties

Other Findings in this Audit

  • 571359 2023-004
    Material Weakness
  • 571360 2023-005
    Significant Deficiency
  • 571361 2023-006
    Significant Deficiency
  • 571362 2023-004
    Material Weakness
  • 571363 2023-005
    Significant Deficiency
  • 571364 2023-006
    Significant Deficiency
  • 571365 2023-004
    Material Weakness
  • 571366 2023-005
    Significant Deficiency
  • 571367 2023-006
    Significant Deficiency
  • 571368 2023-004
    Material Weakness
  • 571369 2023-005
    Significant Deficiency
  • 571370 2023-006
    Significant Deficiency
  • 571371 2023-004
    Material Weakness
  • 571372 2023-005
    Significant Deficiency
  • 571373 2023-006
    Significant Deficiency
  • 571375 2023-005
    Significant Deficiency
  • 571376 2023-006
    Significant Deficiency
  • 571377 2023-004
    Material Weakness
  • 571378 2023-005
    Significant Deficiency
  • 571379 2023-006
    Significant Deficiency
  • 571380 2023-004
    Material Weakness
  • 571381 2023-005
    Significant Deficiency
  • 571382 2023-006
    Significant Deficiency
  • 571383 2023-004
    Material Weakness
  • 571384 2023-005
    Significant Deficiency
  • 571385 2023-006
    Significant Deficiency
  • 1147801 2023-004
    Material Weakness
  • 1147802 2023-005
    Significant Deficiency
  • 1147803 2023-006
    Significant Deficiency
  • 1147804 2023-004
    Material Weakness
  • 1147805 2023-005
    Significant Deficiency
  • 1147806 2023-006
    Significant Deficiency
  • 1147807 2023-004
    Material Weakness
  • 1147808 2023-005
    Significant Deficiency
  • 1147809 2023-006
    Significant Deficiency
  • 1147810 2023-004
    Material Weakness
  • 1147811 2023-005
    Significant Deficiency
  • 1147812 2023-006
    Significant Deficiency
  • 1147813 2023-004
    Material Weakness
  • 1147814 2023-005
    Significant Deficiency
  • 1147815 2023-006
    Significant Deficiency
  • 1147816 2023-004
    Material Weakness
  • 1147817 2023-005
    Significant Deficiency
  • 1147818 2023-006
    Significant Deficiency
  • 1147819 2023-004
    Material Weakness
  • 1147820 2023-005
    Significant Deficiency
  • 1147821 2023-006
    Significant Deficiency
  • 1147822 2023-004
    Material Weakness
  • 1147823 2023-005
    Significant Deficiency
  • 1147824 2023-006
    Significant Deficiency
  • 1147825 2023-004
    Material Weakness
  • 1147826 2023-005
    Significant Deficiency
  • 1147827 2023-006
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.941 Hiv Demonstration, Research, Public and Professional Education Projects $887,872
93.332 Cooperative Agreement to Support Navigators in Federally-Facilitated Exchanges $720,011
93.940 Hiv Prevention Activities Health Department Based $638,227
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $470,256
93.939 Hiv Prevention Activities Non-Governmental Organization Based $420,071
93.994 Maternal and Child Health Services Block Grant to the States $391,322
93.914 Hiv Emergency Relief Project Grants $263,463
93.917 Hiv Care Formula Grants $243,462
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $150,000
93.145 Hiv-Related Training and Technical Assistance $106,520
93.153 Coordinated Services and Access to Research for Women, Infants, Children, and Youth $66,691
93.855 Allergy and Infectious Diseases Research $24,615
93.837 Cardiovascular Diseases Research $10,356
93.977 Sexually Transmitted Diseases (std) Prevention and Control Grants $3,788